Trial NCT02032173

View at ClinicalTrials.gov 
Org. Study IDs: CRFB002DFR11

Last trial update was posted on 2020-10-22

MeSH Interventions

Ranibizumab

MeSH Conditions

Edema Macular Degeneration Macular Edema

Other Conditions

Diabetes

Stopping Reasons

Study was prematurely discontinued as it was unethical to continue based on a change in ranibizumab (RFB) marketing authorization.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID